FDA approves first drug for common form of liver inflammation
By Katherine Dillinger and Jen Christensen, CNN (CNN) — The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH — also known as metabolic dysfunction-associated steatohepatitis, or MASH — happens when the liver becomes inflamed because of excess fat
Continue Reading